Bicycle Therapeutics BCYC reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Bicycle Therapeutics missed estimated earnings by 5.88%, reporting an EPS of $-0.9 versus an estimate of $-0.85.
Revenue was up $2.59 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.25 which was followed by a 5.55% drop in the share price the next day.
Here's a look at Bicycle Therapeutics's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.68 | -0.61 | -0.61 | -0.71 |
| EPS Actual | -0.93 | -0.63 | -0.59 | -0.74 |
| Revenue Estimate | 4.41M | 5.31M | 4.43M | 2.29M |
| Revenue Actual | 3.86M | 3.77M | 4.33M | 1.78M |
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Bicycle Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
